These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Sowers JR; Whaley-Connell A; Epstein M Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712 [TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection. Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393 [TBL] [Abstract][Full Text] [Related]
8. Hypertension and cardiometabolic disease. Tasic I; Lovic D Front Biosci (Schol Ed); 2018 Jan; 10(1):166-174. PubMed ID: 28930524 [TBL] [Abstract][Full Text] [Related]
9. Resistant hypertension in the high-risk metabolic patient. Chaudhary K; Buddineni JP; Nistala R; Whaley-Connell A Curr Diab Rep; 2011 Feb; 11(1):41-6. PubMed ID: 20941645 [TBL] [Abstract][Full Text] [Related]
10. Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update. Ganne S; Arora SK; Dotsenko O; McFarlane SI; Whaley-Connell A Curr Diab Rep; 2007 Jun; 7(3):208-17. PubMed ID: 17547838 [TBL] [Abstract][Full Text] [Related]
11. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Lastra G; Manrique C; Sowers JR Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222 [TBL] [Abstract][Full Text] [Related]
12. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Sowers JR; Frohlich ED Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051 [TBL] [Abstract][Full Text] [Related]
13. The relationship between hyperinsulinemia, hypertension and progressive renal disease. El-Atat FA; Stas SN; McFarlane SI; Sowers JR J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934 [TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? Lioudaki E; Florentin M; Ganotakis ES; Mikhailidis DP Curr Pharm Des; 2013; 19(27):4964-80. PubMed ID: 23278488 [TBL] [Abstract][Full Text] [Related]
16. Diabetes, hypertension, and cardiovascular disease: an update. Sowers JR; Epstein M; Frohlich ED Hypertension; 2001 Apr; 37(4):1053-9. PubMed ID: 11304502 [TBL] [Abstract][Full Text] [Related]
17. Update on the cardiometabolic syndrome. Sowers JR Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324 [TBL] [Abstract][Full Text] [Related]
18. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Whaley-Connell A; Johnson MS; Sowers JR Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958 [TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria in essential hypertension. Mimran A; Ribstein J; Du Cailar G Curr Opin Nephrol Hypertens; 1999 May; 8(3):359-63. PubMed ID: 10456269 [TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade. Menne J; Chatzikyrkou C; Haller H J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]